406 results on '"Orekhov, A.N."'
Search Results
102. 218 SEX HORMONES MODULATE REVERSE CHOLESTEROL TRANSPORT IN HUMAN MACROPHAGES
103. 350 DISTRIBUTION OF HLA-DR-EXPRESSING CELLS IN THE INTIMA OF HUMAN AORTA: POSSIBLE ROLE IN SURVEILLANCE AND MAINTENANCE OF VASCULAR HOMEOSTASIS
104. 349 CELL PROLIFERATION IN DIFFERENT ATHEROSCLEROTIC LESIONS OF HUMAN ARTERIES
105. 739 GENDER DIFFERENCES IN THE DEVELOPMENT OF SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH EARLY SIGNS OF CEREBROVASCULAR INSUFFICIENCY
106. Peculiarities of cell composition and cell proliferation in different type atherosclerotic lesions in carotid and coronary arteries
107. Magnetic Field Statistical Characteristics and Their Relation to the Geological Structure of Quartz–Gold Deposits
108. Corrigendum to “Studies of the human aortic intima by a direct quantitative assay of mutant alleles in the mitochondrial genome” [Atherosclerosis 204 (2009) 184–190]
109. On the Application of Physical and Geological Modeling for the Interpretation of Geophysical Data
110. PO5-116 ASSOCIATION OF SOMATIC MITOCHONDRIAL MUTATIONS WITH ATHEROSCLEROSIS
111. PO5-115 DIRECT QUANTITATIVE ASSESSMENT OF MUTANT ALLELE IN MITOCHONDRIAL GENOME IN ATHEROSCLEROTIC LESION OF HUMAN AORTA
112. YI-844 COMBINED ANTI-INFLAMMATORY AND ANTI-ATHEROGENIC ACTIVITY OF NATURAL DRUG INFLAMINAT — A PERSPECTIVE FOR LONG-TERM ATHEROSCLEROSIS PREVENTION AND TREATMENT
113. PO19-587 BLOOD SERUM ATHEROGENICITY AS A PATHOGENETIC FACTOR FOR ATHEROSCLEROSIS PROGRESSION
114. YI-818 PLURONIC P85 INHIBITS LDL AGGREGATION AND LOWERS LDL-INDUCED INTRACELLULAR CHOLESTEROL ACCUMULATION
115. Th-P15:38 Pluronics inhibit aggregation of low density lipoprotein
116. Th-P15:34 Antibodies associated with LDL are predominately bound to low density lipoprotein aggregates
117. Tu-P7:214 Modified lipoproteins disintegrate intimal network forming by pericytes and dendritic cells
118. We-P14:442 Bioflavonoid-rich botanicals reduce blood serum atherogenicity in perimenopausal women
119. Tu-P8:296 Effect of sex hormones on atherosclerotic indices in primary culture of female cells
120. Tu-P7:209 The reduction of serum atherogenicity by natural anti-inflammatory drug
121. Tu-P7:109 Computer image simulation and mathematic modeling of the very early stage of atherosclerosis in human
122. About petrophysical basis of geophysical prospecting golden ore deposits
123. Binding of native and naturally occurred multiple-modified LDL with elastin of uninvolved and atherosclerotic human aorta
124. The characterization of inflammatory reaction status in grossly normal and atherosclerotic human aorta
125. Atherogenic modification of low density lipoprotein by human blood plasma trans-sialidase
126. Monitoring of carotid atherosclerosis while covering serum atherogenicity: double-blinded placebo-controlled randomized study
127. Comparative study of cell composition in human arteries with clinically significant atherosclerotic sequelae
128. Primary prevention of atherosclerosis with long-acting garlic powder tablets Allicor
129. Deglycosylation is an atherogenic modification of ApoB-containing lipoproteins
130. Senescent and activated pericyte-like cells in human aorta
131. Lipoprotein content in circulating immune complexes as a marker of coronary- and extra-coronary atherosclerosis
132. Human arteries with clinically significant sequelae: The comparative analysis of cell composition
133. Cell proliferation in normal and atherosclerotic human aorta
134. The reduction of estimated cardiovascular risk with Allicor
135. Immune cholesterol as a marker for atherosclerosis
136. Deglycosilation is an atherogenic modification of apo-b-containing lipoproteins
137. Human trans-sialidase produces LDL atherogenic modification
138. Low-density lipoprotein modification occurring in human plasma
139. Continuous subendothelial network formed by pericyte-like cells in human vascular bed
140. 3.P.279 Smooth muscle cells of human aortic intima express CD68 macrophage associated antigen
141. 3.P.95 In vivo and in vitro oxidation of native and modified LDL. Correlation with antioxidant content
142. 3.P.68 Covalent binding of lipids to apolipoprotein B as a marker of LDL oxidation
143. 3.P.139 Atherogenicity of low density lipoprotein does not correlate with the degree of its oxidation
144. 2.P.262 The assessment of risk of myocardial infarction in Moscow population
145. 1.P.201 Anti-atherogenic effect of calcium antagonist plus statin cotreatment realises at lipoprotein level
146. 1.P.202 Verapamil plus garlic: A development of non-lipid-lowering anti-atherogenic therapy
147. 116 Anti-atherogenic effect of calcium antagonist plus statin combination: amlodipine and lovastatin
148. 59 Multiple modification of low density lipoprotein occurring in human plasma
149. Characteristics of low density lipoprotein isolated from circulating immune complexes
150. Gap junctional communication in primary culture of cells derived from human aortic intima
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.